stars 1 stars 2 stars 3

Join our training for Pharma Execs on AI: https://eularis.com/ai-training-for-pharma/ We innovate to solve pharma/biotech/med device business challenges using AI to maximize our clients’ measurable results. We have been in business since 2003 and were the first company to use AI in pharma, and continue to lead in innovation with the projects we participate in. Our teams consist of pharma business strategists, data scientists, big data engineers, full stack developers, computational linguists and user interface designers. Example projects we have done that are powered by AI include: *Finding rare disease patients using AI *Creating chatbots to guide teams to insights in mountains of power point results data *Earlier patient diagnosis *Identifying patients for clinical trials *Personalized individual content and channel delivery to each HCP or patient for maximum engagement *Personalized sales messages by individual physician for sales reps *Hastening reimbursement to formularies *Value based drug pricing Whether you want us to plan a strategy, or do a full end-to-end implementation, or just help with niggling problems your team cannot solve, we are here to help.

Eularis Questions

The Eularis annual revenue was $6.6 million in 2026.

Andree Bates is the Chairman and Founder and CEO and Artificial Intelligence in Pharma Expert of Eularis.

7 people are employed at Eularis.

The NAICS codes for Eularis are [518210, 5182, 51, 518, 51821].

The SIC codes for Eularis are [737, 73].

Top Eularis Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users